All About Cookies is an independent, advertising-supported website. Some of the offers that appear on this site are from third-party advertisers from which All About Cookies receives compensation. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear).
All About Cookies does not include all financial or credit offers that might be available to consumers nor do we include all companies or all available products. Information is accurate as of the publishing date and has not been provided or endorsed by the advertiser.
The All About Cookies editorial team strives to provide accurate, in-depth information and reviews to help you, our reader, make online privacy decisions with confidence. Here's what you can expect from us:
- All About Cookies makes money when you click the links on our site to some of the products and offers that we mention. These partnerships do not influence our opinions or recommendations. Read more about how we make money.
- Partners are not able to review or request changes to our content except for compliance reasons.
- We aim to make sure everything on our site is up-to-date and accurate as of the publishing date, but we cannot guarantee we haven't missed something. It's your responsibility to double-check all information before making any decision. If you spot something that looks wrong, please let us know.
Hims once assured customers that their "medical records and sensitive information are only accessed by the medical providers managing your care."[1]
Now, federal regulators allege the telehealth company shared information about customers' medical treatment interests with advertising platforms, including Meta and Snap.[2]
On November 10, the FTC added five states — Arizona, Florida, Nebraska, Ohio and Wisconsin — to its lawsuit against Hims & Hers Health, Inc.
They join the FTC, Utah, and California, represented by Los Angeles County Counsel Dawyn R. Harrison, in a case first filed in July. The Commission voted 2-0 to authorize the new filing.
The amended complaint spells out numbers that weren't public before. Hims has moved to dismiss the original complaint, and the court has not ruled on any of the claims.
The billing and cancellation allegations
What this means if you've used a telehealth service
What the FTC says Hims did with customer data
Between September 2020 and June 2023, Hims allegedly uploaded roughly 14 million customer email addresses to Meta to create targeted advertising audiences. According to the FTC, Meta matched approximately 10 million of those addresses to user IDs associated with Facebook or Instagram accounts.
Separately, between March 2020 and September 2023, the complaint alleges Hims used uploaded customer email lists to build 90 "Lookalike Audiences," a Meta tool that lets advertisers find new users who resemble an existing customer base.
The complaint alleges the problem wasn't just that Hims uploaded email addresses, but what the lists allegedly told Meta about who was on them. Prosecutors say Hims named many of its Custom and Lookalike Audiences using internal codewords for its treatments, such as "Apollo," "Atlas," and "Zeus."
The complaint alleges internal Meta marketing communications show Meta's staff knew exactly what those code names meant, labeling them internally as corresponding to mental health, premature ejaculation, and erectile dysfunction.
Hims also allegedly sent Meta roughly 8 million "Complete Registration" and "Purchase" tracking events through its website pixel and Conversions API. Those events included identifiers such as email addresses or IP addresses, along with information about the medical treatments customers were seeking. The 8 million figure refers to tracking events, rather than individual customers.
Snap allegedly received five customer lists containing more than 1 million email addresses, with list names revealing interests in mental health and sexual health treatments.
The FTC also says Hims installed advertising pixels from at least 13 other platforms, including Google, Microsoft, Pinterest, Reddit, TikTok and X, and that many of those pixels collected similar health-related information.
According to the complaint, Hims shared sensitive health information with advertisers through at least May 2024 without clearly informing customers.
The billing and cancellation allegations
The data-sharing claims are only part of the case. The complaint also alleges Hims advertised "free" consultations while routinely charging consumers for prescription subscriptions almost immediately after they submitted an online medical intake form, often before any real consultation with a provider took place.
It further alleges Hims made it difficult for consumers to cancel their subscriptions and failed to clearly disclose the dates refill charges would hit their cards.
Hims pushes back
In a statement to Reuters, a Hims & Hers spokesperson said the company "will vigorously defend ourselves against these follow-on claims, which rely on the same flawed allegations advanced in the government's lawsuit."
The case remains in its early stages. These are allegations in a pending lawsuit, and a court has not weighed in on whether any of it holds up.
What this means if you've used a telehealth service
If you use Facebook or Instagram, start by reviewing your advertising and off-platform activity settings. Turn off Facebook tracking and review what information Facebook collects from other websites and apps.
You can also learn how advertisers use cookies to build profiles, although the Hims allegations also involve customer lists and server-side tracking that cookie settings alone can't prevent.
If you've used Hims, Hers or another telehealth service, check its privacy policy for disclosures about sharing information with advertisers. Look for options to limit that sharing or exercise applicable state privacy rights. The protections and opt-out options available to you will depend on the provider and where you live.